Finance

Trending Stocks in Review: Contango Oil & Gas Company (NYSE:MCF) & Applied Genetic Technologies Corporation (NASDAQ:AGTC)

Contango Oil & Gas Company (NYSE:MCF)

Contango Oil & Gas Company is a Houston, Texas based, independent energy company engaged in the acquisition, exploration, development, exploitation and production of crude oil and natural gas offshore in the shallow waters of the Gulf of Mexico and in the onshore Texas and Rocky Mountain regions of the United States.

Contango Oil & Gas Company (NYSE:MCF)’s Financial Overview

Contango Oil & Gas Company (NYSE) declined -1.71% yesterday to close its trading session at $3.45. The company has 1 year Price Target of $5.2. Contango Oil & Gas Company has 52-Week high of $7.32 and 52-Week Low of $2.72. The stock touched its 52-Week High on 7.32 and 52-Week Low on 2.72. The stock traded with the volume of 61858 shares yesterday. The firm shows the market capitalization of $111.92 Million.

Contango Oil & Gas Company (NYSE) reported its last quarterly earnings on 9/29/2018 where the firm reported its Actual EPS of $-3.26/share against the analyst consensus estimate of $-0.15/share. The difference between the actual and expected EPS is $-3.11 a share with a surprise factor of -2073.3%.

The firm is trading with SMA20 of -6.62 Percent, SMA50 of -6.58 Percent and SMA200 of -29.46 percent. Contango Oil & Gas Company has P/S value of 1.43 while its P/B value stands at 0.61. Similarly, the company has Return on Assets of -26 percent, Return on Equity of -45.9 percent and Return on Investment of -6.7 Percent. The company shows Gross Margin and Operating Margin of 65.9 percent and 0 percent respectively.

The Stock currently has Analyst’ mean Recommendation of 2.7 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.

The 6 analysts offering 12-month price forecasts for Contango Oil & Gas Co have a median target of 4.50, with a high estimate of 7.00 and a low estimate of 4.00. The median estimate represents a +30.43% increase from the last price of 3.45.

Contango Oil & Gas Company is estimated to report earnings on 03/08/2019. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates.Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 2 analysts’ forecasts, the consensus EPS forecast for the quarter is $-0.15. The reported EPS for the same quarter last year was $-0.23.

Applied Genetic Technologies Corporation (NASDAQ:AGTC)

Applied Genetic Technologies Corporation is a clinical-stage biotechnology company. It develops gene therapy products for inherited orphan ophthalmology diseases. Its lead product candidates in the preclinical stage include treatments for X-linked retinoschisis, Achromatopsia, and X-linked retinitis pigmentosa, which are diseases of the eye caused by mutations in single genes. Applied Genetic Technologies Corporation is headquartered in Alachua, Florida.

Applied Genetic Technologies Corporation (NASDAQ:AGTC)’s Financial Outlook

The 5 analysts offering 12-month price forecasts for Applied Genetic Technologies Corp have a median target of 5.75, with a high estimate of 15.00 and a low estimate of 5.00. The median estimate represents a +105.36% increase from the last price of 2.80.

Applied Genetic Technologies Corporation is estimated to report earnings on 02/08/2019. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates.Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 3 analysts’ forecasts, the consensus EPS forecast for the quarter is $-0.64. The reported EPS for the same quarter last year was $-0.29.

According to Zacks Investment Research, Applied Genetic Technologies Corporation has a Consensus Recommendation of 1.8. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).

The Stock declined -5.08% and closed its last trading session at $2.8. The company has the market capitalization of $50.96 Million. The stock has 52-week high of $7.5 and 52-Week low of $2.26. The firm touched its 52-Week high on 7.50 and 52-Week low on 2.26. The company has volume of 60782 shares. The company has a total of 18.2 Million shares outstanding.

Applied Genetic Technologies Corporation (NASDAQ) in the last quarter reported its actual EPS of $0.07/share where the analyst estimated EPS was $-0.39/share. The difference between the actual and Estimated EPS is $0.46. This shows a surprise factor of 117.9 percent.

The company has YTD performance of 12.45 percent. Beta for Applied Genetic Technologies Corporation stands at 2.86 while its ATR (average true range) is 0.21. The company has Weekly Volatility of 6.02%% and Monthly Volatility of 7.36%%.

Applied Genetic Technologies Corporation has distance from 20-day Simple Moving Average (SMA20) of -4.35%, Distance from 50-Day Simple Moving Average of -35.87 percent and Distance from 200-Day Simple Moving Average of -41.9%.

The Company currently has ROA (Return on Assets) of -15.2 percent, Return on Equity (ROE) of -19 Percent and Return on Investment (ROI) of -23.4% with Gross margin of 0 percent and Operating & Profit margin of -71.5% and -67% respectively.